Vinegar intake in patients undergoing immune checkpoint inhibitor therapy: food frequency questionnaire study.
Saved in:
| Title: | Vinegar intake in patients undergoing immune checkpoint inhibitor therapy: food frequency questionnaire study. |
|---|---|
| Authors: | Ariizumi H; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Shimazui M; Division of Nutrition, Showa Medical University Hospital, Tokyo, Japan., Ogawa C; Division of Nutrition, Showa Medical University Hospital, Tokyo, Japan., Kaneki M; Division of Nutrition, Showa Medical University Hospital, Tokyo, Japan., Saito N; Division of Nutrition, Showa Medical University Hospital, Tokyo, Japan., Mura E; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Suzuki R; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Tsurui T; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Iriguchi N; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Ishiguro T; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Hirasawa Y; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Shimokawa M; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Ohkuma R; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Kubota Y; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Horiike A; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Wada S; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan.; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Yoshimura K; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan.; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Murakami K; Division of Radiology, Department of Radiology, School of Medicine, Showa Medical University, Tokyo, Japan., Tsunoda T; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Dec 11; Vol. 16, pp. 1640603. Date of Electronic Publication: 2025 Dec 11 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
